VERVE-101: a promising CRISPR-based gene editing therapy that reduces LDL-C and PCSK9 levels in HeFH patients

European Heart Journal - Cardiovascular Pharmacotherapy

23 December 2023
Organised by: Logo
ESC Journals

Contributors

Takahiro Horie
Takahiro Horie

Author

Kyoto University Hospital Kyoto , Japan

Koh Ono
Koh Ono

Author

ESC 365 is supported by